Affordable Access

deepdyve-link
Publisher Website

Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies

Authors
  • Curtis, Brian R.1
  • Hsu, Yen-Michael S.2
  • Podoltsev, Nikolai3
  • Lacy, Jill3
  • Curtis, Susanna3
  • Samuel, Michael S.4
  • Zutavern, Kristin1
  • DeSimone, Robert A.2
  • Bougie, Daniel W.5
  • Aster, Richard H.5, 6
  • 1 The Platelet and Neutrophil Immunology Laboratory, BloodCenter of Wisconsin, Milwaukee, WI;
  • 2 Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;
  • 3 Department of Internal Medicine, Yale University School of Medicine, New Haven, CT;
  • 4 Division of Hematology/Oncology, New York Presbyterian Hospital, New York, NY; and
  • 5 Blood Research Institute, BloodCenter of Wisconsin, and
  • 6 Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
Type
Published Article
Journal
Blood
Publisher
American Society of Hematology
Publication Date
Mar 29, 2018
Volume
131
Issue
13
Pages
1486–1489
Identifiers
DOI: 10.1182/blood-2017-10-812461
PMID: 29439950
PMCID: PMC5877442
Source
PubMed Central
License
Unknown
Report this publication

Statistics

Seen <100 times